Literature DB >> 10813818

Exploration of the S(')(1) subsite of neprilysin: a joined molecular modeling and site-directed mutagenesis study.

C Marie-Claire1, G Tiraboschi, E Ruffet, N Inguimbert, M C Fournie-Zaluski, B P Roques.   

Abstract

Based on the recently described three-dimensional model of the 507-749 region of neprilysin, which contains the catalytic site of the enzyme, experiments were performed to improve the proposed topology of its large and hydrophobic S(')(1) subsite. Docking studies, site-directed mutagenesis, and biochemical studies were combined. The mutations of various residues proposed to be part of the S(')(1) subsite (F563A, F564A, M579A, F716A, and I718A) did not induce major structural reorganization of the active site as demonstrated by the slight modification of the enzyme activity. The mutations were also analyzed by measuring the inhibitory potencies of thiol inhibitors containing P(')(1) moieties of increasing sizes. These results combined with molecular modeling studies support the proposed topology of the S(')(1) subsite. This, and the critical role of F563 and M579 in inhibitor binding, could facilitate the synthesis of new potent and selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813818     DOI: 10.1002/(sici)1097-0134(20000601)39:4<365::aid-prot90>3.0.co;2-t

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  4 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

2.  Computer modeling and nanosecond simulation of the enzyme-substrate complex of the common lymphoblastic leukemia antigen (neprilysin) indicates shared residues at the primary specificity pocket (S1') with matrix metalloproteases.

Authors:  Sergio Manzetti
Journal:  J Mol Model       Date:  2003-08-29       Impact factor: 1.810

Review 3.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

Review 4.  Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis.

Authors:  Deepshikha Mishra; Sunita Singh; Gopeshwar Narayan
Journal:  Mol Biol Int       Date:  2016-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.